Results from a pair of clinical trials evaluating the CAR-T cell therapy Kymriah™ have demonstrated long-lasting remissions in non-Hodgkin’s lymphoma patients.
Researchers at The institute of Cancer Research (London, UK) have identified six genetic changes that increase the risk of developing Hodgkin lymphoma.
Researchers have presented the association between tumor response and health-related quality of life in patients with metastatic Merkel cell carcinoma treated with avelumab.
In this research article find out how researchers developed a prognostic score for primary breast cancer patients integrating conventional predictors and the novel biomarker CHAC1 to aid adjuvant chemotherapy decisions.
Discover the importance of a pharmacologic Polycomb signature in predicting the prognosis of breast and gastric cancer in this Short Communication article from Epigenomics.